Federal law now guarantees fertility treatment access, overriding state bans.
H.R. 2049 — Access to Family Building Act · Filed by Laura Gillen (D-NY) · 76 cosponsors · Introduced Mar 11, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a federal statutory right for individuals to access assisted reproductive technology (ART) and related fertility services without state or local restrictions that are more burdensome than comparable medical procedures, do not meaningfully advance safety, or unduly limit access. It grants health care providers the right to offer ART services and insurers the right to cover them, and establishes federal enforcement mechanisms—including private lawsuits and attorney's fees—to override conflicting state laws.
Why we flagged it
The bill's core mechanism is a federal statutory right to access fertility services and enforcement against state restrictions. It is fundamentally a rights-expansion and preemption statute, not a funding or regulatory carve-out.
What the text implies
- The bill's preemption language (Section 5) is extremely broad—it supersedes all state law, common law, and future federal law unless explicitly excluded by name. This may create conflict with state insurance regulation, religious exemption statutes, and medical licensing standards that do not explicitly reference this Act.
- The private right of action with mandatory attorney's fees (Section 4(5)) creates a powerful enforcement tool but may generate high-volume litigation against state officials and local governments, with significant cost exposure even for non-frivolous defenses.
The full analysis lists 5 implications of this text.
Who stands to gain
fertility clinics and reproductive medicine providers; health insurance companies (expanded coverage market); pharmaceutical companies (fertility drugs and treatments)